Skip to main content
. 2023 Jun 3;43(6):413–420. doi: 10.1007/s40261-023-01275-6

Table 1.

Pharmacokinetic parameters of venglustat after a single oral dose of 15 mg administration in healthy Chinese volunteers

 Parameter Female volunteers (n = 7) Male volunteers (n = 7) All volunteers (N = 14)
Cmax (ng/mL)
 Mean ± SD 62.7 ± 20.7 57.9 ± 14.5 60.3 ± 17.3
 Geometric mean (CV) 59.6 (33%) 56.4 (25%) 58.0 (29%)
tmax (h), median (range) 3.00 (2.00–5.00) 2.00 (1.00–3.00) 2.50 (1.00–5.00)
tlast (h), median (range) 120.00 (120.00–120.00) 120.00 (120.00–120.00) 120.00 (120.00–120.00)
AUC0–24 (ng·h/mL)
 Mean ± SD 950 ± 295 922 ± 208 936 ± 245
 Geometric mean (CV) 909 (31%) 904 (23%) 906 (26%)
AUClast (ng·h/mL)
 Mean ± SD 1970 ± 708 2250 ± 506 2110 ± 610
 Geometric mean (CV) 1860 (36%) 2200 (22%) 2020 (29%)
AUCinf (ng·h/mL)
 Mean ± SD 2040 ± 740 2530 ± 603 2280 ± 697
 Geometric mean (CV) 1920 (36%) 2460 (24%) 2170 (31%)
t1/2z (h)
 Mean ± SD 24.6 ± 1.68 36.6 ± 5.71 30.6 ± 7.40
 Geometric mean (CV) 24.6 (7%) 36.2 (16%) 29.8 (24%)
CL/F (L/h)
 Mean ± SD 8.29 ± 3.05 6.24 ± 1.47 7.27 ± 2.54
 Geometric mean (CV) 7.82 (37%) 6.09 (24%) 6.90 (35%)
Vss/F (L)
 Mean ± SD 283 ± 88.3 318 ± 63.5 300 ± 76.1
 Geometric mean (CV) 271 (31%) 312 (20%) 291 (25%)
MRT (h)
 Mean ± SD 34.8 ± 2.94 51.8 ± 8.54 43.3 ± 10.8
 Geometric mean (CV) 34.7 (8%) 51.2 (16%) 42.2 (25%)

AUC, area under the plasma concentration–time curve; AUCinf, AUC extrapolated to infinity; AUC0–24, AUC from time = 0 h to 24 h after drug administration; AUClast, AUC from time = 0 h to last measurable concentration; Cmax, maximum plasma concentration; CL/F, apparent systemic clearance from plasma; CV, coefficient of variation; Cmax, maximum concentration; h, hour; L, liter; mL, milliliter; MRT, mean residence time; ng, nanogram; SD, standard deviation; t1/2z, terminal half-life; tmax, time to Cmax; tlast, time of last measurable concentration; Vss/F, apparent volume of distribution at steady state